These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18089729)

  • 1. Protective effect of low-concentration chlorine dioxide gas against influenza A virus infection.
    Ogata N; Shibata T
    J Gen Virol; 2008 Jan; 89(Pt 1):60-67. PubMed ID: 18089729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of influenza virus haemagglutinin by chlorine dioxide: oxidation of the conserved tryptophan 153 residue in the receptor-binding site.
    Ogata N
    J Gen Virol; 2012 Dec; 93(Pt 12):2558-2563. PubMed ID: 22933663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low-concentration chlorine dioxide gas against bacteria and viruses on a glass surface in wet environments.
    Morino H; Fukuda T; Miura T; Shibata T
    Lett Appl Microbiol; 2011 Dec; 53(6):628-34. PubMed ID: 21950421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.
    Hayden FG; Treanor JJ; Betts RF; Lobo M; Esinhart JD; Hussey EK
    JAMA; 1996 Jan 24-31; 275(4):295-9. PubMed ID: 8544269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaseous chlorine dioxide as an alternative for bedbug control.
    Gibbs SG; Lowe JJ; Smith PW; Hewlett AL
    Infect Control Hosp Epidemiol; 2012 May; 33(5):495-9. PubMed ID: 22476276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses.
    Leneva IA; Roberts N; Govorkova EA; Goloubeva OG; Webster RG
    Antiviral Res; 2000 Nov; 48(2):101-15. PubMed ID: 11114412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin.
    Jeon SH; Kayhan B; Ben-Yedidia T; Arnon R
    J Biol Chem; 2004 Nov; 279(46):48410-9. PubMed ID: 15358767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
    Sidwell RW; Huffman JH; Barnard DL; Bailey KW; Wong MH; Morrison A; Syndergaard T; Kim CU
    Antiviral Res; 1998 Feb; 37(2):107-20. PubMed ID: 9588843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sheng Jiang San, a traditional multi-herb formulation, exerts anti-influenza effects in vitro and in vivo via neuraminidase inhibition and immune regulation.
    Zhang T; Xiao M; Wong CK; Mok KC; Zhao X; Ti H; Shaw PC
    BMC Complement Altern Med; 2018 May; 18(1):150. PubMed ID: 29739459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies.
    Leyva-Grado VH; Tan GS; Leon PE; Yondola M; Palese P
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4162-72. PubMed ID: 25941218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza viral neuraminidase primes bacterial coinfection through TGF-β-mediated expression of host cell receptors.
    Li N; Ren A; Wang X; Fan X; Zhao Y; Gao GF; Cleary P; Wang B
    Proc Natl Acad Sci U S A; 2015 Jan; 112(1):238-43. PubMed ID: 25535343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.
    Kido H; Okumura Y; Yamada H; Le TQ; Yano M
    Curr Pharm Des; 2007; 13(4):405-14. PubMed ID: 17311557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus.
    Kash JC; Basler CF; García-Sastre A; Carter V; Billharz R; Swayne DE; Przygodzki RM; Taubenberger JK; Katze MG; Tumpey TM
    J Virol; 2004 Sep; 78(17):9499-511. PubMed ID: 15308742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies.
    Horváth A; Andersen I; Junker K; Lyck Fogh-Schultz B; Holm Nielsen E; Gizurarson S; Andersen O; Kármán J; Rajnavölgyi E; Erdei A; Svehag SE
    Antiviral Res; 2001 Oct; 52(1):43-53. PubMed ID: 11530187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
    Ives JA; Carr JA; Mendel DB; Tai CY; Lambkin R; Kelly L; Oxford JS; Hayden FG; Roberts NA
    Antiviral Res; 2002 Aug; 55(2):307-17. PubMed ID: 12103431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo.
    Carr J; Ives J; Kelly L; Lambkin R; Oxford J; Mendel D; Tai L; Roberts N
    Antiviral Res; 2002 May; 54(2):79-88. PubMed ID: 12062393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a fully human monoclonal antibody against multiple influenza A viral strains in mice and a pandemic H1N1 strain in nonhuman primates.
    Song A; Myojo K; Laudenslager J; Harada D; Miura T; Suzuki K; Kuni-Kamochi R; Soloff R; Ohgami K; Kanda Y
    Antiviral Res; 2014 Nov; 111():60-8. PubMed ID: 25218949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).
    Matassov D; Cupo A; Galarza JM
    Viral Immunol; 2007 Sep; 20(3):441-52. PubMed ID: 17931114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety Evaluation of a Chlorine Dioxide Solution.
    Ma JW; Huang BS; Hsu CW; Peng CW; Cheng ML; Kao JY; Way TD; Yin HC; Wang SS
    Int J Environ Res Public Health; 2017 Mar; 14(3):. PubMed ID: 28327506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.